Caspase-3 and caspase-6 cleave STAT1 in leukemic cells

Area of Science:

• Molecular biology
• Cellular signaling
• Cancer research

Background:

• Signal transducer and activator of transcription-1 (STAT1) plays a dual role in cell fate, inhibiting proliferation but sometimes promoting survival in cancer.
• Overexpression and constitutive activation of STAT1 are observed in certain malignancies.
• Interferon (IFN) stimulation typically leads to STAT1 phosphorylation, impacting cell proliferation and survival.

Purpose of the Study:

• To investigate the effect of histone deacetylase inhibitors (HDACi) on STAT1 in transformed hematopoietic cells.
• To identify the caspases responsible for STAT1 cleavage induced by HDACi.
• To determine the specificity of STAT1 cleavage in different cell types.

Main Methods:

• Treatment of transformed hematopoietic cells with HDAC inhibitors.
• In vitro cleavage assays using purified STAT1 and candidate caspases.
• Mass spectrometry to identify cleavage sites.
• Comparative analysis of STAT1 cleavage in solid tumor cells, normal hematopoietic cells, and differentiated leukemic cells.

Main Results:

• HDACi treatment induced STAT1 cleavage at multiple sites by caspase-3 and caspase-6 in transformed hematopoietic cells.
• STAT1 cleavage was not observed in solid tumor cells, normal hematopoietic cells, or differentiated leukemic cells (granulocytic or monocytic).
• Purified STAT1 was directly cleaved by caspase-3 and caspase-6 under cell-free conditions.

Conclusions:

• STAT1 is a direct target of caspase-3 and caspase-6 in malignant, undifferentiated hematopoietic cells.
• The observed STAT1 cleavage mechanism may contribute to the selective toxicity of HDAC inhibitors against rapidly proliferating leukemic cells.
• This finding highlights a specific vulnerability in certain hematologic malignancies.